市場調査レポート

商品コード

1647398

陽子線治療市場の評価、製品タイプ別、適応症別、セットアップタイプ別、最終用途別、地域別、機会および予測、2018-2032年

Proton Therapy Market Assessment, By Product Type, By Indications, By Setup Type, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日: 2025年02月03日
発行: Market Xcel - Markets and Data
ページ情報: 英文 225 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 646,065円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 818,349円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,177,274円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の陽子線治療は、2025～2032年の予測期間中にCAGR 8.00%を記録し、2024年の7億6,834万米ドルから2032年には14億2,214万米ドルに成長すると予測されています。米国国立がん研究所は、米国では623,405人が転移性がんに罹患しており、2025年には693,453人に増加すると予測しています。そのため、進行がんに対する効果的な治療に対するニーズが高まっています。放射線治療とは異なり、陽子線治療は副作用が少ないです。これは、放射線療法が標的部位の近傍の組織を損傷するのに対し、陽子線治療は正常細胞を損傷することなくがん細胞のみを標的とするためです。陽子線治療は副作用が少ないため、治療法として人気を博しています。したがって、陽子線治療は非常に効果的で、健康な組織への影響も少ないため、その需要と価値は上昇し続けると思われます。

その他の要因としては、副作用が少なく有効率の高い治療法に対する需要の高まり、陽子線治療センターの急速な拡大、ペンシルビームスキャニングなど治療効率を高める技術開発、保険適用の拡大、がん対策における政府の取り組みの増加、腫瘍微小環境をよりよく理解し効果的な治療法の利用可能性を高めるためのがん生物学研究の重要性の高まりなどが挙げられます。

世界的に陽子線治療センターが増加し、アクセスやキャパシティが向上していることも市場成長を後押ししています。コンパクトで費用対効果の高い陽子線治療システムの導入が進むにつれ、この先進技術を採用する病院やがん治療施設が増えています。2024年5月、IBA（Ion Beam Applications S.A.）はコネチカット陽子線治療センター（イェール・ニューヘブン・ヘルス、ハートフォード・ヘルスケア、プロトン・インターナショナルのパートナーシップ）とProteus ONE陽子線治療システムの設置契約を締結しました。この契約は複数年にわたる保守契約であり、患者は2026年春に治療を受ける予定です。この契約は複数年の保守契約であり、患者は2026年春に治療を受ける予定です。この契約は、患者が現地まで移動する際の負担を軽減しつつ、治療時間を厳守することを目的としています。新興市場のセンターは、陽子線治療に対する患者の信頼を高めるのに役立つ認知度を生み出し、精密ベースのがん治療ソリューションに対する世界のニーズの高まりに応えます。

市場規模の分析と予測
- 金額別
- 数量別
市場シェア分析と予測
- 製品タイプ別
  - システム
  - サービス
- 適応症別
  - 頭頸部がん
  - 中枢神経系がん
  - 前立腺がん
  - 乳がん
  - 肺がん
  - 小児がん
  - 消化器がん
  - その他
- セットアップタイプ別
  - シングルルームシステム
  - マルチルームシステム
- 最終用途別
  - 病院
  - 陽子線治療センター
  - がんセンターまたは研究所
- 地域別
  - 北米
  - 欧州
  - アジア太平洋
  - 南米
  - 中東およびアフリカ
- 企業別市場シェア分析（上位5社およびその他- 金額別、2024年）
市場マップ分析、2024年
- 製品タイプ別
- 適応症別
- セットアップタイプ別
- 最終用途別
- 地域別

第5章北米陽子線治療市場の展望、2018年～2032年

市場規模の分析と予測
- 金額別
- 数量別
市場シェア分析と予測
- 製品タイプ別
  - システム
  - サービス
- 適応症別
  - 頭頸部がん
  - 中枢神経系がん
  - 前立腺がん
  - 乳がん
  - 肺がん
  - 小児がん
  - 消化器がん
  - その他
- セットアップタイプ別
  - シングルルームシステム
  - マルチルームシステム
- 最終用途別
  - 病院
  - 陽子線治療センター
  - がんセンターまたは研究所
- 国別シェア
  - 米国
  - カナダ
  - メキシコ
国別市場評価
- 米国陽子線治療市場の見通し、2018年～2032年
  - 市場規模の分析と予測
  - 市場シェア分析と予測
- カナダ
- メキシコ

すべてのセグメントは、対象となるすべての地域と国で提供されます。

第6章欧州陽子線治療市場の展望、2018年～2032年

ドイツ
フランス
イタリア
英国
ロシア
オランダ
スペイン
ポーランド

第7章アジア太平洋の陽子線治療市場の展望、2018年～2032年

インド
中国
日本
オーストラリア
ベトナム
韓国
インドネシア
フィリピン

第8章南米陽子線治療市場の展望、2018年～2032年

ブラジル
アルゼンチン

第9章中東およびアフリカの陽子線治療市場の見通し、2018年～2032年

サウジアラビア
アラブ首長国連邦
南アフリカ
イスラエル

第10章需要供給分析

第11章輸入と輸出の分析

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第14章 PESTLE分析

第15章価格分析

第16章市場力学

市場促進要因
市場の課題

第17章市場の動向と発展

第18章規制枠組みとイノベーション

イノベーション
規制当局の承認

第19章特許の情勢

第20章ケーススタディ

第21章競合情勢

市場リーダー上位5社の競合マトリックス
トップ5企業のSWOT分析
市場トップ10の主要企業の情勢
- Hitachi, Ltd.
- Ion Beam Applications（IBA）SA
- Mevion Medical Systems, Inc.
- Toshiba Energy Systems &Solutions Corporation
- Sumitomo Heavy Industries, Ltd.
- Optivus Proton Therapy, Inc.
- Varian Medical Systems, Inc.
- Mitsubishi Electric Corporation
- Provision Solutions, LLC
- ProTom International, Inc.

上記の企業は市場シェアに基づいて注文を保留しておらず、調査作業中に入手可能な情報に基づいて変更される可能性があります。

第22章戦略的提言

第23章調査会社について・免責事項

図表

List of Tables

Table 1. Competition Matrix of Top 5 Market Leaders
Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1.Global Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 2.Global Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 3.Global Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 4.Global Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 5.Global Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 6.Global Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 7.Global Proton Therapy Market Share (%), By Region, 2018-2032F
Figure 8.North America Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 9.North America Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 10.North America Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 11.North America Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 12.North America Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 13.North America Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 14.North America Proton Therapy Market Share (%), By Country, 2018-2032F
Figure 15.United States Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 16.United States Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 17.United States Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 18.United States Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 19.United States Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 20.United States Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 21.Canada Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 22.Canada Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 23.Canada Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 24.Canada Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 25.Canada Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 26.Canada Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 27.Mexico Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 28.Mexico Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 29.Mexico Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 30.Mexico Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 31.Mexico Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 32.Mexico Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 33.Europe Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 34.Europe Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 35.Europe Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 36.Europe Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 37.Europe Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 38.Europe Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 39.Europe Proton Therapy Market Share (%), By Country, 2018-2032F
Figure 40.Germany Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 41.Germany Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 42.Germany Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 43.Germany Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 44.Germany Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 45.Germany Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 46.France Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 47.France Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 48.France Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 49.France Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 50.France Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 51.France Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 52.Italy Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 53.Italy Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 54.Italy Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 55.Italy Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 56.Italy Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 57.Italy Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 58.United Kingdom Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 59.United Kingdom Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 60.United Kingdom Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 61.United Kingdom Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 62.United Kingdom Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 63.United Kingdom Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 64.Russia Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 65.Russia Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 66.Russia Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 67.Russia Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 68.Russia Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 69.Russia Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 70.Netherlands Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 71.Netherlands Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 72.Netherlands Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 73.Netherlands Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 74.Netherlands Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 75.Netherlands Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 76.Spain Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 77.Spain Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 78.Spain Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 79.Spain Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 80.Spain Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 81.Spain Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 82.Turkey Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 83.Turkey Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 84.Turkey Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 85.Turkey Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 86.Turkey Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 87.Turkey Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 88.Poland Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 89.Poland Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 90.Poland Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 91.Poland Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 92.Poland Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 93.Poland Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 94.South America Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 95.South America Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 96.South America Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 97.South America Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 98.South America Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 99.South America Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 100.South America Proton Therapy Market Share (%), By Country, 2018-2032F
Figure 101.Brazil Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 102.Brazil Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 103.Brazil Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 104.Brazil Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 105.Brazil Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 106.Brazil Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 107.Argentina Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 108.Argentina Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 109.Argentina Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 110.Argentina Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 111.Argentina Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 112.Argentina Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 113.Asia-Pacific Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 114.Asia-Pacific Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 115.Asia-Pacific Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 116.Asia-Pacific Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 117.Asia-Pacific Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 118.Asia-Pacific Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 119.Asia-Pacific Proton Therapy Market Share (%), By Country, 2018-2032F
Figure 120.India Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 121.India Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 122.India Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 123.India Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 124.India Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 125.India Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 126.China Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 127.China Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 128.China Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 129.China Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 130.China Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 131.China Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 132.Japan Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 133.Japan Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 134.Japan Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 135.Japan Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 136.Japan Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 137.Japan Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 138.Australia Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 139.Australia Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 140.Australia Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 141.Australia Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 142.Australia Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 143.Australia Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 144.Vietnam Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 145.Vietnam Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 146.Vietnam Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 147.Vietnam Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 148.Vietnam Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 149.Vietnam Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 150.South Korea Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 151.South Korea Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 152.South Korea Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 153.South Korea Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 154.South Korea Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 155.South Korea Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 156.Indonesia Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 157.Indonesia Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 158.Indonesia Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 159.Indonesia Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 160.Indonesia Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 161.Indonesia Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 162.Philippines Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 163.Philippines Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 164.Philippines Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 165.Philippines Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 166.Philippines Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 167.Philippines Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 168.Middle East & Africa Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 169.Middle East & Africa Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 170.Middle East & Africa Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 171.Middle East & Africa Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 172.Middle East & Africa Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 173.Middle East & Africa Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 174.Middle East & Africa Proton Therapy Market Share (%), By Country, 2018-2032F
Figure 175.Saudi Arabia Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 176.Saudi Arabia Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 177.Saudi Arabia Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 178.Saudi Arabia Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 179.Saudi Arabia Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 180.Saudi Arabia Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 181.UAE Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 182.UAE Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 183.UAE Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 184.UAE Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 185.UAE Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 186.UAE Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 187.South Africa Proton Therapy Market, By Value, In USD Million, 2018-2032F
Figure 188.South Africa Proton Therapy Market, By Volume, In Million Units, 2018-2032F
Figure 189.South Africa Proton Therapy Market Share (%), By Product Type, 2018-2032F
Figure 190.South Africa Proton Therapy Market Share (%), By Indications, 2018-2032F
Figure 191.South Africa Proton Therapy Market Share (%), By Setup Type, 2018-2032F
Figure 192.South Africa Proton Therapy Market Share (%), By End-user, 2018-2032F
Figure 193.By Product Type Map-Market Size (USD Million) & Growth Rate (%), 2024
Figure 194.By Indications Map-Market Size (USD Million) & Growth Rate (%), 2024
Figure 195.By Setup Type Map-Market Size (USD Million) & Growth Rate (%), 2024
Figure 196.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2024
Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2024

Product Code: MX12689

Global proton therapy is projected to witness a CAGR of 8.00% during the forecast period 2025-2032, growing from USD 768.34 million in 2024 to USD 1422.14 million in 2032. The rising prevalence of cancer is promoting the growth of the market; the National Cancer Institute has stated that 623,405 people in the United States are living with metastatic cancer, and this is expected to rise to 693,453 by 2025. Therefore, there is a growing need for effective treatment for advanced-stage cancer. Unlike radiation therapy, proton therapy produces fewer side effects. This is because radiation therapy damages the tissues near the targeted area, while proton therapy only targets cancerous cells without damaging the normal cells. Proton therapy has fewer side effects and, hence, has gained popularity for treatment. Therefore, demand and value for proton therapy will keep rising because the treatment is quite effective and has a minimal impact on healthy tissues.

Other factors include higher demand for treatments that have a better effectiveness rate with fewer side effects, the rapid expansion of proton therapy centers, technological developments that enhance treatment efficiency, such as pencil beam scanning, increased insurance coverage, increasing government initiatives in cancer control, and the growing importance given to research on cancer biology to understand the tumor microenvironment better and boost the availability of effective treatments.

The growing number of proton therapy centers worldwide with improved access and capacity enhances market growth. As compact and cost-effective proton therapy systems are increasingly installed, more hospitals and cancer treatment facilities are adopting this advanced technology. In May 2024, IBA (Ion Beam Applications S.A.) signed a contract with Connecticut Proton Therapy Center (a Partnership with Yale New Haven Health, Hartford HealthCare, and Proton International) to install a Proteus ONE proton therapy system. The agreement is a multiyear maintenance deal, and patients are expected to receive treatment in spring 2026. The agreement is a multiyear maintenance deal, and patients are expected to receive treatment in spring 2026. It is designed to alleviate burdens associated with patients traveling to sites while being on time with treatments. Centers in emerging markets create an awareness that helps increase patients' confidence in proton therapy, hence catering to the growing global need for precision-based cancer treatment solutions.

Growing Government Initiatives Boost Market Demand

Proton therapy is becoming increasingly popular due to increasing government efforts to develop more advanced cancer treatment facilities and healthcare infrastructure. Governments worldwide are investing in advanced medical devices and technologies to improve cancer care, thereby driving the adoption of proton therapy. In July 2024, Romania's Ministry of Health invested USD 123.276 million (EUR 120 million) in a project to build the country's first proton therapy center, thereby improving its healthcare infrastructure. This center will offer advanced cancer treatment, minimizing patients' need to go abroad and boosting demand and market growth for proton therapy in Romania. Moreover, market growth is also bolstering as more people become aware of the advantages of proton therapy over traditional radiation therapy, which includes higher precision in targeting tumors and fewer side effects. Establishing specialized healthcare centers and public-private partnerships further improves access to this cutting-edge therapy. Also, favorable policies, research funding, and infrastructure updates in emerging nations are accelerating the establishment of proton therapy centers, meeting the rising demand for innovative cancer treatment solutions.

Rising Research Activities Support Market Expansion

The proton therapy market is rapidly growing, driven by increased research activities emphasizing its clinical advantages and diversifying its uses. A study in proton therapy presented in 2024 at the American Society of Clinical Oncology (ASCO) annual meeting highlighted proton therapy as a potential new standard-of-care treatment for controlling head and neck malignancies. This study found that proton therapy provides superior precision in targeting tumors while protecting healthy surrounding tissues, lowering side effects, and improving patient quality of life. Such research findings provide persuasive evidence of proton therapy's superiority over traditional radiation therapies, and this evidence fueled the interest of healthcare providers as well as researchers. Such research is driving major investments in proton therapy technologies and infrastructure. As more clinical data emerges, the growing acknowledgment of proton therapy's benefits speeds up its adoption, building a strong foundation for sustained growth in the worldwide cancer domain.

Single-Room Systems; the Fastest Growing Segment in the Market

The single-room proton therapy system segment is expected to grow significantly during the forecast period, owing to its cost-effectiveness, compact design, and rising need for easily accessible cancer treatment options. Single-room systems, as compared to multi-room systems, require less space and lesser initial investments, making them an appealing option for smaller healthcare facilities and growing markets. There has been a noticeable increase in the installation of single-room systems, especially for cancer treatment, which supports this trend. Many cancer centers are currently using these systems to accurately treat localized tumors while lowering infrastructure costs. Moreover, the compact design of these single-room systems also facilitates faster installation and operational readiness, which helps medical professionals to better handle increasing cancer loads. In June 2024, the MEVION S250-FIT Proton Therapy System, a compact single-room system, was installed at Carol G. Simon Cancer Center (at Morristown Medical Center, U.S.). This new system, which will be utilized for service in 2025, will improve radiation oncology treatments and accelerate the growth of the single-room systems segment. Because of its clinical effectiveness, affordability, and scalability, positioning single-room systems plays a crucial role in the market expansion of proton therapy.

North America Dominates the Global Proton Therapy Market Share

North America is currently dominating the proton therapy market and holds a significant share because of various key factors contributing to its solid position in the market. The region has a well-established healthcare system, with advanced equipment to integrate new technologies such as proton therapy. The geriatric population in the U.S. has increased, leading to higher cases of cancer, thereby increasing the demand for advanced therapies. These supportive reimbursement policies of the U.S. healthcare system have relieved the financial barrier for patients and practitioners in adopting proton therapy. Continued growth in the number of centers providing proton therapy across the United States is due to private investment and government programs. These centers provide increased access to high-precision cancer treatment. For instance, in September 2024, UC Regents approved the UCSF cancer treatment center, including a proton therapy center, research space, life sciences incubator, and clinics in San Francisco's Dogpatch Power Station. The UCSF Life Sciences Building will provide advanced cancer care and innovative research facilities. Moreover, awareness among healthcare professionals and patients about the benefits of proton therapy is increased, which adds to the region's dominant position in the global market.

Future Market Scenario (2025 - 2032F)

The proton therapy market is expected to see substantial growth in the coming years with advancements in technology, increasing investment, and an increased awareness level worldwide. Another reason for this growth is the growing developments in compact proton therapy centers that need less space and have lower costs than multi-room systems. This compact solution brings proton therapy to the forefront of smaller health facilities and new markets. Investment in private and public sectors drives innovation, resulting in more efficient and cost-effective systems and enhanced treatment options. In July 2024, Australia invested USD 721 million in the Queensland Cancer Centre, which is expected to open in 2028. The center will offer proton beam therapy and other advanced treatments that increase the precision of cancer treatment. This is expected to propel the growth of the proton therapy market. Moreover, expanding cancer care institutes also supports market growth. For instance, BayCare Cancer Institute will open a 'compact' proton therapy center in 2025. Advanced technology allows for acceleration in construction, as the machines do not take up as much space as traditional ones. This will fuel further market growth because proton therapy is easier to access and has a reduced cost.

Furthermore, with a growing incidence of cancer and a desire for more precise, minimally invasive treatments, the market continues to expand rapidly. Proton therapy is bound to be transformative in the treatment of cancer going forward as infrastructural development and further clinical evidence will establish its superiority.

Key Players Landscape and Outlook

Key market players in the proton therapy market are strengthening their position through continuous technological innovation, collaborations, and geographic expansion. For instance, they invest in compact, cost-effective systems and optimize treatment precision. Increasing partnerships with healthcare service providers and research organizations accelerate adoption and market growth.

In January 2025, IBA (Ion Beam Applications SA) signed a deal with AIG Hospitals under which the latter committed to spend USD 96 million (Rs 800 crore) for equipping a Proteus ONE Proton Therapy System. This sophisticated acquisition, involving DynamicARC technology, will elevate IBA as a market leader in proton therapy equipment and service supply. It emphasizes IBA's commitment to developing cancer treatment technology and extending its international reach in the healthcare market.

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Proton Therapy Market Outlook, 2018-2032F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. Market Share Analysis & Forecast
- 4.2.1. By Product Type
  - 4.2.1.1. Systems
    - 4.2.1.1.1. Cyclotron
    - 4.2.1.1.2. Synchrotron
    - 4.2.1.1.3. Synchrocyclotron
  - 4.2.1.2. Services
- 4.2.2. By Indications
  - 4.2.2.1. Head and Neck Cancer
  - 4.2.2.2. Central Nervous System Cancer
  - 4.2.2.3. Prostate Cancer
  - 4.2.2.4. Breast Cancer
  - 4.2.2.5. Lung Cancer
  - 4.2.2.6. Pediatric Cancer
  - 4.2.2.7. Gastrointestinal Cancer
  - 4.2.2.8. Others
- 4.2.3. By Setup Type
  - 4.2.3.1. Single-Room Systems
  - 4.2.3.2. Multi-Room Systems
- 4.2.4. By End-user
  - 4.2.4.1. Hospitals
  - 4.2.4.2. Proton Therapy Centers
  - 4.2.4.3. Cancer Centers or Institutes
- 4.2.5. By Region
  - 4.2.5.1. North America
  - 4.2.5.2. Europe
  - 4.2.5.3. Asia-Pacific
  - 4.2.5.4. South America
  - 4.2.5.5. Middle East and Africa
- 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
4.3. Market Map Analysis, 2024
- 4.3.1. By Product Type
- 4.3.2. By Indications
- 4.3.3. By Setup Type
- 4.3.4. By End-user
- 4.3.5. By Region

5. North America Proton Therapy Market Outlook, 2018-2032F*

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
- 5.1.2. By Volume
5.2. Market Share Analysis & Forecast
- 5.2.1. Product Type
  - 5.2.1.1. Systems
    - 5.2.1.1.1. Cyclotron
    - 5.2.1.1.2. Synchrotron
    - 5.2.1.1.3. Synchrocyclotron
  - 5.2.1.2. Services
- 5.2.2. By Indications
  - 5.2.2.1. Head and Neck Cancer
  - 5.2.2.2. Central Nervous System Cancer
  - 5.2.2.3. Prostate Cancer
  - 5.2.2.4. Breast Cancer
  - 5.2.2.5. Lung Cancer
  - 5.2.2.6. Pediatric Cancer
  - 5.2.2.7. Gastrointestinal Cancer
  - 5.2.2.8. Others
- 5.2.3. By Setup Type
  - 5.2.3.1. Single-Room Systems
  - 5.2.3.2. Multi-Room Systems
- 5.2.4. By End-user
  - 5.2.4.1. Hospitals
  - 5.2.4.2. Proton Therapy Centers
  - 5.2.4.3. Cancer Centers or Institutes
- 5.2.5. By Country Share
  - 5.2.5.1. United States
  - 5.2.5.2. Canada
  - 5.2.5.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Proton Therapy Market Outlook, 2018-2032F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
    - 5.3.1.1.2. By Volume
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. Product Type
      - 5.3.1.2.1.1. Systems
      - 5.3.1.2.1.1.1. Cyclotron
      - 5.3.1.2.1.1.2. Synchrotron
      - 5.3.1.2.1.1.3. Synchrocyclotron
      - 5.3.1.2.1.2. Services
    - 5.3.1.2.2. By Indications
      - 5.3.1.2.2.1. Head and Neck Cancer
      - 5.3.1.2.2.2. Central Nervous System Cancer
      - 5.3.1.2.2.3. Prostate Cancer
      - 5.3.1.2.2.4. Breast Cancer
      - 5.3.1.2.2.5. Lung Cancer
      - 5.3.1.2.2.6. Pediatric Cancer
      - 5.3.1.2.2.7. Gastrointestinal Cancer
      - 5.3.1.2.2.8. Others
    - 5.3.1.2.3. By Setup Type
      - 5.3.1.2.3.1. Single-Room Systems
      - 5.3.1.2.3.2. Multi-Room Systems
    - 5.3.1.2.4. By End-user
      - 5.3.1.2.4.1. Hospitals
      - 5.3.1.2.4.2. Proton Therapy Centers
      - 5.3.1.2.4.3. Cancer Centers or Institutes
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Proton Therapy Market Outlook, 2018-2032F

6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Poland

7. Asia-Pacific Proton Therapy Market Outlook, 2018-2032F

7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines

8. South America Proton Therapy Market Outlook, 2018-2032F

8.1. Brazil
8.2. Argentina

9. Middle East and Africa Proton Therapy Market Outlook, 2018-2032F

9.1. Saudi Arabia
9.2. UAE
9.3. South Africa
9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

16.1. Market Drivers
16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

18.1. Innovations
18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

21.1. Competition Matrix of Top 5 Market Leaders
21.2. SWOT Analysis for Top 5 Players
21.3. Key Players Landscape for Top 10 Market Players
- 21.3.1. Hitachi, Ltd.
  - 21.3.1.1. Company Details
  - 21.3.1.2. Key Management Personnel
  - 21.3.1.3. Products and Services
  - 21.3.1.4. Financials (As Reported)
  - 21.3.1.5. Key Market Focus and Geographical Presence
  - 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
- 21.3.2. Ion Beam Applications (IBA) SA
- 21.3.3. Mevion Medical Systems, Inc.
- 21.3.4. Toshiba Energy Systems & Solutions Corporation
- 21.3.5. Sumitomo Heavy Industries, Ltd.
- 21.3.6. Optivus Proton Therapy, Inc.
- 21.3.7. Varian Medical Systems, Inc.
- 21.3.8. Mitsubishi Electric Corporation
- 21.3.9. Provision Solutions, LLC
- 21.3.10. ProTom International, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

陽子線治療市場の評価、製品タイプ別、適応症別、セットアップタイプ別、最終用途別、地域別、機会および予測、2018-2032年

Proton Therapy Market Assessment, By Product Type, By Indications, By Setup Type, By End-user, By Region, Opportunities and Forecast, 2018-2032F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の陽子線治療市場の展望、2018年～2032年

第5章 北米陽子線治療市場の展望、2018年～2032年

第6章 欧州陽子線治療市場の展望、2018年～2032年

第7章 アジア太平洋の陽子線治療市場の展望、2018年～2032年

第8章 南米陽子線治療市場の展望、2018年～2032年

第9章 中東およびアフリカの陽子線治療市場の見通し、2018年～2032年

第10章 需要供給分析

第11章 輸入と輸出の分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析